Safety of the COVID-19 vaccine booster in patients with immunobullous diseases: A cross-sectional study of the International Pemphigus and Pemphigoid Foundation.

Kasperkiewicz, Michael; Strong, Rebecca; Yale, Marc; Dunn, Patrick; Woodley, David T

Kasperkiewicz, Michael; Strong, Rebecca; Yale, Marc; Dunn, Patrick; Woodley, David T.

Afiliação

Kasperkiewicz M; Department of Dermatology, Keck School of Medicine, University of Southern California, Los Angeles, California, USA.
Strong R; International Pemphigus and Pemphigoid Foundation, Roseville, California, USA.
Yale M; International Pemphigus and Pemphigoid Foundation, Roseville, California, USA.
Dunn P; International Pemphigus and Pemphigoid Foundation, Roseville, California, USA.
Woodley DT; Department of Dermatology, Keck School of Medicine, University of Southern California, Los Angeles, California, USA.

J Eur Acad Dermatol Venereol ; 37(1): e9-e10, 2023 01.

Article em En | MEDLINE | ID: mdl-35964297

Assuntos

COVID-19; Penfigoide Bolhoso; Pênfigo; Dermatopatias; Humanos; Estudos Transversais; COVID-19/prevenção & controle

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Dermatopatias / Penfigoide Bolhoso / Pênfigo / COVID-19 Tipo de estudo: Observational_studies / Prevalence_studies Limite: Humans Idioma: En Revista: J Eur Acad Dermatol Venereol Assunto da revista: DERMATOLOGIA / DOENCAS SEXUALMENTE TRANSMISSIVEIS Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google